Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight The software as a medical device market is experiencing strong growth, driven by the...
Aro Biotherapeutics Appoints Biotechnology Executive Brett Blackman, Ph.D., to its Board of Directors
GlobeNewswire, Inc.
PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aro Biotherapeutics, a clinical-stage biotechnology company developing targeted short-interfering RNA (siRNA) medicines for the treatment of diseases with high unmet medical need, today announced...
Dr. Ricardo Schwarcz Announces New Scholarship for Healthcare Sciences to Support Future Medical Leaders Across the USA
GlobeNewswire, Inc.
HARLINGEN, Texas, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The Dr. Ricardo Schwarcz Scholarship for Healthcare Sciences announces its opening for applications, offering a unique opportunity for undergraduate students nationwide who demonstrate a...
Dr. Matt Kaeberlein Joins The Cat Health Company’s Scientific Advisory Board
EIN Presswire
Dr. Kaeberlein, a founding figure in the science of companion-animal aging, brings decades of expertise to The Cat Health Company’s work on aging.
TekniPlex Healthcare to Showcase Wearable Drug Delivery, Ophthalmic Innovations, and Pharmaceutical Protection at CPHI Milan 2026
GlobeNewswire, Inc.
Wayne, PA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The materials that protect and deliver medicines are changing.
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
GlobeNewswire, Inc.
SAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced data published in the Proceedings of the National...
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
GlobeNewswire, Inc.
FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule.
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
GlobeNewswire, Inc.
SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization...
Nxera Announces Successful Resolution of miniG Patent Infringement Action
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited (“Nxera”) has entered into a settlement agreement...
Uphold Launches Industry-First XRP, BTC and HBAR Inheritance Solution for its Integrated Self-Custody Wallet
GlobeNewswire, Inc.
San Francisco, CA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Uphold, the modern infrastructure provider for on-chain finance, today announced the launch of Vault Inheritance, a new feature designed to solve an often overlooked crypto challenge: how to...
DCL International Marks 40 Years of Engineering Innovation
GlobeNewswire, Inc.
TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- DCL International Inc. (DCL), part of the DCL Technology Group and a global leader in advanced catalytic technologies, celebrates its 40th anniversary with the launch of a refreshed brand identity that...
Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
GlobeNewswire, Inc.
TEL AVIV, Israel, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that the...
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
GlobeNewswire, Inc.
ROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress...
CEA Industries Inc. to Become BNB Standard Corporation After Open Community Advisory Vote
GlobeNewswire, Inc.
Nearly 6,000 advisory votes cast on four shortlisted names Common stock continues to trade on Nasdaq under “BNC” LOUISVILLE, CO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC) (“CEA Industries,” “BNC,” or the “Company”), a...
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
GlobeNewswire, Inc.
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Caspian Therapeutics, Inc. (“Caspian”), a biotechnology company developing menin inhibitors for diabetes and other cardiometabolic diseases, today announced the appointments of Manasi Jaiman, M.D.,...
GATC Health's Derisq Named One of The Scientist's 2026 Top Innovations
GlobeNewswire, Inc.
GATC’s Derisq™, the definitive AI report for predictive risk intelligence, named a Top Emerging Startup Technology by independent panel of life sciences experts at the esteemed publication.
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
GlobeNewswire, Inc.
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic...
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
GlobeNewswire, Inc.
PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today...
Fieldguide Reaches Agreement with CPA Canada to Embed Trusted Canadian Engagement Forms within Industry-Leading Agentic AI
GlobeNewswire, Inc.
SAN FRANCISCO and TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Fieldguide, the leading transformation partner for agentic audit and advisory, today announced a new agreement with CPA Canada to embed the organization's trusted Professional...
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
GlobeNewswire, Inc.
CLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today...
Sign up for:
Technology News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.